State IL
Clinical Trials in Illinois
Recruiting clinical trials with at least one study location in Illinois. Data updated daily from ClinicalTrials.gov.
Top Conditions in Illinois
NCT06526819 Phase 1, Phase 2
Recruiting
SMP-3124LP in Adults With Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
120 pts
Location
United States, Japan
Sponsor
Sumitomo Pharma America, Inc.
NCT06572228 Phase 4
Recruiting
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Be...
Condition
Asthma
Enrollment
250 pts
Location
United States, Canada, Denmark
Sponsor
Regeneron Pharmaceuticals
NCT04047628 Phase 3
Recruiting
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for ...
Condition
Relapsing Multiple Sclerosis
Enrollment
156 pts
Location
United States
Sponsor
National Institute of Allergy
NCT00920972 Phase 1, Phase 2
Recruiting
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Condition
Metabolic Disorders
Enrollment
220 pts
Location
United States, Canada
Sponsor
Washington University School o
NCT05407636 Phase 3
Recruiting
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Condition
AMD
Enrollment
660 pts
Location
United States, Canada, France
Sponsor
AbbVie
NCT05712200 Phase 3
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients Wi...
Condition
Atrial Fibrillation (AF)
Enrollment
1,900 pts
Location
United States, Argentina, Brazil
Sponsor
Anthos Therapeutics, Inc.
NCT06880692 N/A
Recruiting
The Tick App: Changing Behaviors With Educational Messaging
Condition
Tick Bites
Enrollment
3,500 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06850922 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ...
Condition
Diabetic Macular Edema
Enrollment
546 pts
Location
United States, China, Puerto Rico
Sponsor
Genentech, Inc.
NCT06071767 Phase 1, Phase 2
Recruiting
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in ...
Condition
HIV-1-infection
Enrollment
36 pts
Location
United States, Brazil
Sponsor
National Institute of Allergy
NCT05083481 Phase 1, Phase 2
Recruiting
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembro...
Condition
Advanced Solid Tumors
Enrollment
366 pts
Location
United States, China, France
Sponsor
Astellas Pharma Global Develop
NCT06828471 N/A
Recruiting
Social Cognition Training in Individuals With Huntington's Disease
Condition
Huntington's Disease (HD)
Enrollment
20 pts
Location
United States
Sponsor
Rush University Medical Center
NCT05810064 N/A
Recruiting
Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emer...
Condition
Falls-Risk
Enrollment
30,000 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT04578665 N/A
Recruiting
Human-like Robotic Controllers for Enhanced Motor Learning
Condition
Stroke
Enrollment
764 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
NCT04496687 N/A
Recruiting
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
Condition
Spontaneous Coronary Artery Dissection
Enrollment
1,000 pts
Location
United States, Australia
Sponsor
SCAD Alliance
NCT06617871 N/A
Recruiting
Mechanical Alignment vs Kalipered Kinematic Alignment Total Knee Arthroplasty
Condition
Knee Osteoarthritis
Enrollment
95 pts
Location
United States
Sponsor
Northwestern University
NCT07076199 Phase 3
Recruiting
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing ...
Condition
Diabetes Mellitus, Type 1
Enrollment
877 pts
Location
United States, Australia, Canada
Sponsor
Novo Nordisk A/S
NCT06559306 Phase 3
Recruiting
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Part...
Condition
Depressive Disorder, Major
Enrollment
752 pts
Location
United States, Argentina, Brazil
Sponsor
Janssen Research & Development
NCT06212947 N/A
Recruiting
A Multicenter Multinational Observational Study of Children With Hypochondroplas...
Condition
Hypochondroplasia
Enrollment
400 pts
Location
United States, Argentina, Australia
Sponsor
BioMarin Pharmaceutical
NCT06575426 Phase 1, Phase 2
Recruiting
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF...
Condition
Diabetes Mellitus, Type 1
Enrollment
13 pts
Location
United States
Sponsor
Otsuka Pharmaceutical Factory,
NCT06676930 N/A
Recruiting
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
Condition
Colon Polyps
Enrollment
180 pts
Location
United States
Sponsor
Northwestern University
NCT05885698 N/A
Recruiting
MYLUNG Consortium Part 3: Observational Study
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
7,500 pts
Location
United States
Sponsor
US Oncology Research
NCT05329584 N/A
Recruiting
InSpace Accelerated Rehabilitation Study
Condition
Rotator Cuff Tears
Enrollment
160 pts
Location
United States
Sponsor
Stryker Endoscopy
NCT05130255 Phase 1
Recruiting
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
Condition
SCLC
Enrollment
60 pts
Location
United States
Sponsor
Y-mAbs Therapeutics
NCT06743126 Phase 3
Recruiting
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously T...
Condition
Melanoma, Cutaneous Malignant
Enrollment
360 pts
Location
United States, Canada, Germany
Sponsor
Immatics US, Inc.